2 Biotechs With Recent FDA Approvals to Hold for the Next Decade

2 Biotechs With Recent FDA Approvals to Hold for the Next Decade

Source: 
Motley Fool
snippet: 
  • Legend Biotech is looking to bring its newly approved CAR-T cell therapy into earlier treatment lines.
  • Immunocore brought the first-ever TCR immunotherapy to market earlier this year.
  • Both companies could expand into much larger addressable markets in the coming years.